Valuation Eurofins Scientific SE

Stocks

Real-time Euronext Paris Other stock markets 06:32:50 2026-07-03 EDT			5-day change	1st Jan Change
69.08 ^EUR	-0.09%		+0.17%	+10.71%

06-30	NFL Biosciences validates industrial-scale production of NFL-102 for smoking cessation
06-04	Eurofins Scientific SE acquired High North Laboratories.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	20,893	12,900	11,336	9,273	11,036	12,082	-	-
Change	-	-38.26%	-12.13%	-18.2%	19.02%	9.48%	-	-
Enterprise Value (EV) ¹	23,132	15,739	14,041	12,269	14,677	15,524	15,167	14,796
Change	-	-31.96%	-10.79%	-12.62%	19.63%	5.77%	-2.3%	-2.44%
P/E	27.8x	22.2x	45.4x	26.9x	28x	24x	18.4x	15.5x
PBR	4.49x	2.7x	2.24x	1.73x	2.56x	2.52x	2.27x	2.07x
PEG	-	-1x	-0.8x	0.7x	1.3x	0.8x	0.6x	0.8x
Capitalization / Revenue	3.11x	1.92x	1.74x	1.33x	1.51x	1.59x	1.5x	1.39x
EV / Revenue	3.44x	2.34x	2.16x	1.77x	2.01x	2.04x	1.88x	1.71x
EV / EBITDA	12.2x	10.4x	10.3x	7.91x	8.94x	8.98x	8x	7.12x
EV / EBIT	15.7x	15.2x	16.7x	12.1x	13.6x	14.2x	12.2x	10.6x
EV / FCF	22.8x	23.2x	29.6x	15.3x	16.7x	21.6x	17.2x	15.3x
FCF Yield	4.39%	4.3%	3.38%	6.53%	5.97%	4.64%	5.8%	6.56%
Dividend per Share ²	1	1	0.5	0.5	0.72	0.7704	0.8987	0.9605
Rate of return	0.92%	1.49%	0.85%	1.01%	1.15%	1.11%	1.3%	1.39%
EPS ²	3.91	3.02	1.3	1.83	2.23	2.88	3.75	4.473
Distribution rate	25.6%	33.1%	38.5%	27.3%	32.3%	26.8%	24%	21.5%
Net sales ¹	6,718	6,712	6,515	6,951	7,296	7,600	8,074	8,666
EBITDA ¹	1,902	1,513	1,364	1,552	1,641	1,729	1,896	2,078
EBIT ¹	1,473	1,037	842	1,017	1,079	1,093	1,240	1,392
Net income ¹	783	606	310	406	475	516.7	676.2	795.9
Net Debt ¹	2,239	2,839	2,705	2,996	3,641	3,442	3,085	2,714
Reference price ²	108.80	67.06	58.98	49.31	62.40	69.14	69.14	69.14
Nbr of stocks (in thousands)	192,035	192,365	192,194	188,049	176,864	174,751	-	-
Announcement Date	2/22/22	3/1/23	2/27/24	1/30/25	1/29/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
EUROFINS SCIENTIFIC SE	24.01x	2.04x	8.98x	1.11%	13.83B
LONZA GROUP AG	34.02x	5.98x	18.5x	0.96%	49.15B
REVOLUTION MEDICINES, INC.	-23.69x	348.44x	-22.41x	-.--%	40.23B
IQVIA HOLDINGS INC.	25.19x	2.79x	12.06x	-.--%	34.55B
BEONE MEDICINES AG	44.97x	4.49x	28.67x	-.--%	33.09B
CELLTRION, INC.	29.73x	7.68x	19.76x	0.42%	25.19B
MEDPACE HOLDINGS, INC.	32.72x	5.32x	24.23x	-.--%	15.92B
ICON PUBLIC LIMITED COMPANY	24.5x	1.94x	11.76x	-.--%	13.26B
IONIS PHARMACEUTICALS, INC.	-22.69x	14.88x	-22.26x	-.--%	13.52B
Average	18.75x	43.73x	8.81x	0.28%	26.53B
Weighted average by Cap.	19.68x	63.21x	9.36x	0.31%